Sensory attenuation is related to dopamine dose in Parkinson’s disease
Noham Wolpe, Jiaxiang Zhang, Cristina Nombela, James N. Ingram, Daniel M. Wolpert, Cam-CAN, LORRAINE KOMISARJEVSKY TYLER, Carol Brayne, Edward Thomas Bullmore, Andrew C. Calder, Rhodri Cusack, Tim Dalgleish, John Duncan, Fiona E. Matthews, William D. Marslen‐Wilson, , James Benedict Rowe
This study investigates how dopamine levels in Parkinson’s disease patients affect sensory attenuation during voluntary movements, finding a negative correlation with motor severity and a positive correlation with dopamine dose.
Scientific Reports · Oct 17, 2018Peer-reviewedNeuroscience